期刊文献+

UCA1在肾癌中的表达分析及临床意义研究 被引量:5

The expression and clinical significance of UCA1 in renal cell carcinoma
原文传递
导出
摘要 目的检测长链非编码RNA UCA1在肾癌组织、肾癌细胞系中的表达水平,比较配对组织间、细胞系之间的表达差异,分析UCA1表达水平与患者临床特征之间的关系,探究其在肾癌中的临床意义。方法提取肾癌细胞系及46对配对组织中的总RNA,反转录获得c DNA后通过实时荧光定量PCR方法检测UCA1的表达量,使用统计学软件分析UCA1表达的差异性及其表达水平与患者临床特征之间的相关性。结果 UCA1在肾癌组织中表达水平明显高于配对癌旁正常组织(P<0.001),在肾癌细胞(786-O、ACHN、769P、Caki-2)中表达水平高于人胚肾细胞(293T)(P<0.001)。标本中共有38例(82.609%)肾癌标本UCA1表达上调,癌组织中UCA1表达量与患者临床特征无明显相关性(P>0.05)。结论 UCA1在肾癌组织及细胞系中表达明显上调,提示其和肾癌的发生发展有一定关系。 Objective To detect the expression level of lnc RNA UCA1 in the renal cell carcinoma and cell lines. Then compare the expression in paired tissues and different cell lines, and analyze the relationships between the expression level of UCA1 and clinical characteristics to explore UCA1's clinical significance in renal cell carcinoma. Methods Total RNA was isolated from RCC cell lines and46 paired tissues, and the total RNA was used to get c DNA by performing reverse transcription. Then realtime quantitative PCR(RT-q PCR) was used to detect the expression of UCA1. Statistic analysis was performed to explore the differences of UCA1's expression level and the relationships between the expression of UCA1 and clinical characteristics. Results The expression level of UCA1 was significantly higher in RCC tissues(P〈0.001) than paired normal tissues. And the expression of UCA1 in cell lines(786-O, ACHN, 769 P, Caki-246) was higher than the human embryo kidney cell line(293T)(P〈0.001). 38(82.609%) RCC tissues showed up-regulation in all tissues which were detected. The results showed that there was no relationships between the expression of UCA1 and patients' clinical characteristics.Conclusion RCC tissues and cell lines UCA1 is up-regulated, and this indicates that it may be involved in the tumorigenesis and development of RCC.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第7期23-26,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金(81101922) 广东省医学科研基金(A2012584 A2013606) 2013年深圳市科技研发资金知识创新计划基础研究项目(JCYJ20130402114702124) 广东省重点医学专科经费
关键词 肾肿瘤 肿瘤分期 长链非编码RNA UCA1 Kidney neoplasms Neoplasm staging lnc RNAs UCA1
  • 相关文献

参考文献16

  • 1Tostain J, Li G; Gentil-Perrct A, et al. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnusis, prognosis and treatment[J]. Eur J Cancer, 2010, 46(18): 3141-3148.
  • 2Rasmussen F. Metastatic renal cell cancer[J]. Cancer Imaging, 2013,13(3): 374-380.
  • 3Siegel P,,, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
  • 4Cairns R Renal ~ell carcinoma[J]. Cancer Biomark, 2010. 9(1/6): 461-473.
  • 5Wang ZX, Li JL, Cao JX, et al. Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled recta-analysis[J]. Immunotherapy, 2014, 6(6): 787-795.
  • 6Li Z, Li X, Wu S, et al. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/ microRNA143 pathway[J]. Cancer Sci, 2014, 105(8): 951-955.
  • 7Kraus TF, G-reiner A, Guibourt V, et al, Long non-coding RNA normalisers in human brain tissue[J]. J Neural Transm, 2014.
  • 8Tian Y, Zhang X, Hao Y, et al. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma[J]. Melanoma Res, 2014, 24(4): 335-341.
  • 9Ma MZ, Chu BF, Zhang Y, et al. Long non-coding RNA CCATI promotes gallbladder cancer developm~at via negative modulation of miRNA-218-Sp[J]. Cell Death Dis, 2015, 6: e1583.
  • 10Han Y, Yang YN, Yuan HH, et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution[J]. Pathology, 2014, 46(5): 396-401.

同被引文献60

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [ J ]. CA Cancer J Clin ,2015,65 ( 1 ) :5-29.
  • 2Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [Jl. CA Cancer J Clin,2015,65(2) :87-108.
  • 3Leibovieh BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma[ Jl. J Urol,2010,183(4) :1309-1315.
  • 4Eisenhauer EA,Therasse P, Bogaerts J,et al. New response evalu- ation criteria in solid tumours:revised RECIST guideline (version 1.1 ) [ J ]. Eur J Cancer, 2009,45 ( 2 ) : 228-247.
  • 5Cancer Genome Atlas Research N. Comprehensive molecular char- acterization of clear cell renal cell carcinoma [ J ]. Nature, 2013, 499 (7456) :43-49.
  • 6Li J, Han L, Roebuck P, et al. TANRIC : an interactive open plat- form to explore the function of lncRNAs in cancer [ J ]. Cancer Res,2015,75 (18) :3728-3737.
  • 7Liu L,Shao X,Gao W,et al. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor[ J J. FEBS J ,2012,279 (20) :3800-3812.
  • 8Lain JS, Shvarts O, Said JW, et al. Clinicopathologic and molecu- lar correlations of necrosis in the primary tumor of patients with renal cell carcinoma [ J ]. Cancer,2005,103 ( 12 ) :2517-2525.
  • 9Hudes G, Carducci M, Tomczak P, eta|. Temsirolimus, interferon alfa,or both for advanced renal-cell carcinoma [ J ]. N Engl J Med,2007,356 ( 22 ) : 2271-2281.
  • 10谢小娟,李旭,王帆,陈葳.非编码RNAUCA1基因的细胞定位和组织表达谱分析[J].南方医科大学学报,2010,30(1):57-60. 被引量:38

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部